Merck KGaA Obtains CE mark Approval for Gavi and Geri
Merck KGaA has received CE mark approval for the two new advanced fertility technologies Gavi and Geri. This will allow […]
Tags: automated and standardized protocol, biology, Business Partnership, Cryobiology, Embryo, european union, Fertility, Fertility medicine, fertility technologies, Genea Biomedx, Human reproduction, in vitro fertilisation, Kommanditgesellschaft auf Aktien, Merck KGaA, MERCK Kommanditgesellschaft auf Aktien, pregnancy, Reproduction
Jubilant Life Sciences receives ANDA approvals for Mycophenolate Mofetil and Rizatriptan
Jubilant Life Sciences Ltd, an integrated Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval […]
HLFPPT provides one-stop solution for corporates under new CSR regime
For profit-making companies grappling with the problem of finding suitable welfare projects under the new CSR regime, HLFPPT, one of […]
Cirrius Wireless designs marketing network for pharma giant
Pharmaceutical firm Merck Ltd announced recently that it has partnered with software firm Cirrius Wireless Technologies for providing mobile-based solution, marketing network and activation system (MANAS) to its sales representatives across the country.
Antiretroviral drugs to fight HIV/ AIDS
The antiretroviral drugs (ARVs) are designed to do interrupt the HIV/ AIDS virus at various points.
